Page last updated: 2024-12-05

ethyl stearate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Ethyl stearate is a colorless, odorless, and tasteless fatty acid ester that is produced by the esterification of stearic acid with ethanol. It is a common ingredient in cosmetics, pharmaceuticals, and food products. Ethyl stearate is used as a lubricant, emulsifier, and thickener. It is also used as a plasticizer, which means that it can soften and make materials more flexible. Ethyl stearate is a biodegradable compound and is considered safe for human use. It is studied for its potential applications in various fields, including drug delivery, tissue engineering, and biocompatible materials.'

stearic acid ethyl ester: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

ethyl octadecanoate : An octadecanoate ester obtained by formal condensation between the carboxy group of octadecanoic (stearic) acid and the hydroxy group of ethanol. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID8122
CHEBI ID84936
SCHEMBL ID24287
MeSH IDM0086603

Synonyms (63)

Synonym
ai3-01781
einecs 203-887-4
fema no. 3490
nsc 8919
brn 1788183
nsc-8919
nsc8919
ethyl n-octadecanoate
ethyl octadecanoate
stearic acid, ethyl ester
111-61-5
octadecanoic acid, ethyl ester
stearic acid ethyl ester
ethyl stearate
dicyclohexylammonium sulfate
ethyl stearate, >=97%
ethyl stearate, >=99% (capillary gc)
FT-0668391
QSPL 088
QSPL 077
QSPL 085
QSPL 080
octacecanoic acid, ethy ester
S0365
S0079
AKOS004910332
QSPL 132
CHEBI:84936
c64rtc734w ,
unii-c64rtc734w
4-02-00-01218 (beilstein handbook reference)
ethyl octadecanoate [fhfi]
ethyl stearate [usp-rs]
ethyl stearate [inci]
stearic acid ethyl ester [mi]
SCHEMBL24287
ethyl-stearate
DTXSID5059406
radia 7185
HMS3650O05
mfcd00009006
J-002604
LMFA07010883
ethyl stearate, united states pharmacopeia (usp) reference standard
ethyl stearate, analytical standard
ethyl stearate, vetec(tm) reagent grade, 97%
octadecanoic acid-ethyl ester
ethyl stearate; octadecanoic acid ethyl ester
dicyclohexylammonium sulphate
ethyl octadecanoate (ethyl stearate)
ethyloctadecanoate
ethyl ocatadecanoate
fema 3490
sr-01000946815
SR-01000946815-1
Q9344811
D92247
ethylstearate
BS-42291
A894706
CS-W014525
HY-W013809
ethyl stearate, 1mg/ml in acetonitrile

Research Excerpts

Compound-Compound Interactions

NSCs transplantation combined with ethyl stearate ameliorated the behavioral deficits of PD rats. NSCs migration from the striatum to the substantia nigra via CCL5/CCR5 and promoting the differentiation of N SCs into dopaminergic neurons.

ExcerptReferenceRelevance
"NSCs transplantation combined with ethyl stearate ameliorated the behavioral deficits of PD rats."( Neural stem cells transplantation combined with ethyl stearate improve PD rats motor behavior by promoting NSCs migration and differentiation.
Chen, D; Huang, J; Li, C; Li, H; Li, X; Yang, X; Ye, S; Yi, L; Zheng, Q; Zhong, J, 2023
)
1.44
"These findings suggest that NSCs transplantation combined with ethyl stearate can improve the motor behavioral performance of PD rats by promoting NSCs migration from the striatum to the substantia nigra via CCL5/CCR5 and promoting the differentiation of NSCs into dopaminergic neurons."( Neural stem cells transplantation combined with ethyl stearate improve PD rats motor behavior by promoting NSCs migration and differentiation.
Chen, D; Huang, J; Li, C; Li, H; Li, X; Yang, X; Ye, S; Yi, L; Zheng, Q; Zhong, J, 2023
)
1.41
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
plant metaboliteAny eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
long-chain fatty acid ethyl esterA fatty acid ethyl ester resulting from the formal condensation of the carboxy group of a long-chain fatty acid with the hydroxy group of ethanol.
octadecanoate esterA fatty acid ester obtained by condensation of the carboxy group of stearic acid with the hydroxy group of any alcohol or phenol.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (22)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (9.09)18.7374
1990's0 (0.00)18.2507
2000's8 (36.36)29.6817
2010's9 (40.91)24.3611
2020's3 (13.64)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 40.88

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index40.88 (24.57)
Research Supply Index3.30 (2.92)
Research Growth Index5.31 (4.65)
Search Engine Demand Index53.71 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (40.88)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other26 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]